Immunogenicity of an HPV-16 L2 DNA vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunogenicity of an HPV-16 L2 DNA vaccine

Published:2009-10 Issue:46 Volume:27 Page:6432-6434
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Hitzeroth Inga I.,Passmore Jo-Ann S.,Shephard Enid,Stewart Debbie,Müller Martin,Williamson Anna-Lise,Rybicki Edward P.,Kast W. Martin

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference12 articles.

1. Vaccination strategies for the prevention of cervical cancer;Maclean;Expert Reviews Anticancer Therapy,2005

2. Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers;Kawana;Vaccine,2003

3. DNA vaccines for cervical cancer: from bench to bedside;Hung;Experimental and Molecular Medicine,2007

4. Generation and characterization of a preventative and therapeutic HPV DNA vaccine;Kim;Vaccine,2008

5. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice;Hanke;Vaccine,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses;Molecular Biotechnology;2021-07-25

2. Combination of human papillomaviruses L1 and L2 multiepitope constructs protects mice against tumor cells;Fundamental & Clinical Pharmacology;2021-06-16

3. PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model;Cancer Immunology, Immunotherapy;2020-10-27

4. Detection of specific antibody-ligand interactions with a self-induced back-action actuated nanopore electrophoresis sensor;Nanotechnology;2019-11-26

5. In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine;Scientific Reports;2019-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3